References
- DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
- YoshidaTTuderRMPathobiology of cigarette smoke-induced chronic obstructive pulmonary diseasePhysiol Rev20078731047108217615396
- SorianoJBSinDDZhangXA pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placeboChest2007131368268917356080
- AranaLGangoitiPOuroATruebaMGómez-MuñozACeramide and ceramide 1-phosphate in health and diseaseLipids Health Dis201091520137073
- ScarpaMCBaraldoSMarianECeramide expression and cell homeostasis in chronic obstructive pulmonary diseaseRespiration201385434234923018286
- PetracheINatarajanVZhenLCeramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in miceNat Med200511549149815852018
- BodasMMinTMazurSVijNCritical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysemaJ Immunol2011186160261321135173
- BrodlieMMcKeanMCJohnsonGECeramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung diseaseAm J Respir Crit Care Med2010182336937520395562
- DemedtsIKDemoorTBrackeKRJoosGFBrusselleGGRole of apoptosis in the pathogenesis of COPD and pulmonary emphysemaRespir Res2006715316571143
- SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
- TeichgräberVUlrichMEndlichNCeramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosisNat Med200814438239118376404
- ClarkeCJHannunYANeutral sphingomyelinases and nSMase-2: bridging the gapsBiochim Biophys Acta20061758121893190116938269
- UhligSGulbinsESphingolipids in the lungsAm J Respir Crit Care Med2008178111100111418755926
- LevyMKhanECareagaMGoldkornTNeutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell deathAm J Physiol Lung Cell Mol Physiol20092971L125L13319395669
- DonnellyLEBarnesPJDefective phagocytosis in airways diseaseChest201214141055106222474147
- BerensonCSKruzelRLEberhardtESethiSPhagocytic dysfunction of human alveolar macrophages and severity chronic obstructive pulmonary diseaseJ Infect Dis2013208122036204523908477
- HodgeSMatthewsGMukaroVCigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteineAm J Respir Cell Mol Biol201144567368120595463
- FilostoSCastilloSDanielsonANeutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injuryAm J Respir Cell Mol Biol201144335036020448054
- PlumbJSmythLJAdamsHRVestboJBentleyASinghSDIncreased T-regulatory cells within lymphocyte follicles in moderate COPDEur Respir J2009341899419196820
- RendaTBaraldoSPelaiaGIncreased activation of p38 MAPK in COPDEur Respir J2008311626917959643
- GaffeyKReynoldsSPlumbJKaurMSinghDIncreased phosphorylated p38 mitogen-activated protein kinase in COPD lungsEur Respir J2013421284123060629
- BazzanESaettaMTuratoGExpression of the atypical chemokine receptor D6 in human alveolar macrophages in COPDChest201314319810622797410
- WallaceAMLoyLBAbboundRTExpression of matrix metalloproteinase-1 in alveolar macrophages, type II pneumocytes, and airways in smokers: relationship to lung function and emphysemaLung2014192446747224792232
- PlumbJRobinsonLLeaSEvaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionatePLoS One201385e6425723704983
- MerrillAHJrSullardsMCAllegoodJCKellySWangESphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometryMethods200536220722415894491
- EjsingSMoehringTBahrUCollision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion traporbitrap mass spectrometryJ Mass Spectrom20064137238916498600
- SakataAOchiaiTShimenoHAcid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in miceImmunology20071221546417451462
- WangSHYangWBLiuYCA potent sphingomyelinase inhibitor from Cordyceps mycelia contributes its cytoprotective effect against oxidative stress in macrophagesJ Lipid Res201152347147921217100
- MedlerTRPetruscaDNLeePJApoptotic sphingolipid signaling by ceramides in lung endothelial cellsAm J Respir Cell Mol Biol200838663964618192502
- LevyMCastilloSSGoldkornTnSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosisBiochem Biophys Res Commun2006344390090516631623
- MillerMEAdhikarySKolokoltsovAADaveyRAEbolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infectionJ Virol201286147473748322573858
- ShaykhievRKrauseASalitJSmoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary diseaseJ Immunol200918342867288319635926
- VeckaMTvrzickáEStankováBNovákFNovákováOZákAHypolipidemic drugs can change the composition of rat brain lipidsTohoku J Exp Med2004204429930815572855